​Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

Publication Title

SITC 2021

Authors

• Brie Chun, Earle A. Chiles Research Institute, 4805 N.E. Glisan St., North Tower, Suite 2N87, Portland, OR, 97213, USA.Follow
• Joanna Pucilowska, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, ORFollow
• Shu-Ching Chang, Medical Data Research Center, Providence Health & Services, Portland, OR, USAFollow
• Isaac Kim, Earle A. Chiles Research Institute, 4805 N.E. Glisan St., North Tower, Suite 2N87, Portland, OR, 97213, USA.Follow
• Benjamin Nikitin, ProvidenceFollow
• Yoshinobu Koguchi, Robert W Franz Cancer Center, Earle A Chiles Research Institute, Portland, OR, USAFollow
• William L. Redmond, Earle A Chiles Research InstituteFollow
• Brady Bernard, Institute for Systems Biology, Seattle, WA 98109.Follow
• Venkatesh Rajamanickam, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, ORFollow
• Nathan Polaske
• Paul Fields
• Valerie Conrad, Earle A. Chiles Research Institute, Portland, OR; Providence Cancer Institute, Portland, ORFollow
• Mark Schmidt, Providence Cancer Institute, Portland, ORFollow
• Walter Urba, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, 97213, USA.Follow
• Alison Conlin, Providence Cancer Center, Portland, Oregon.Follow
• Heather McArthur
• David B Page, Providence Cancer Center, Earle A. Chiles Research Institute Portland , OR , USAFollow

Document Type

Presentation

Publication Date

2021

Keywords

oregon; washington

Area of Special Interest

Cancer

Area of Special Interest

Women & Children

Specialty/Research Institute

Oncology